According to the Australian Ocean Health announcement, the cumulative deviation value of the company's stock closing price fell by more than 20% for three consecutive trading days on November 4, November 5, and November 6, 2026, which is an abnormal fluctuation in stock trading. After self-inspection and a letter to the controlling shareholder, as of the date of disclosure of the announcement, there was no material information that should have been disclosed but not disclosed, and the controlling shareholder did not trade the company's shares during the period of abnormal fluctuations. As of the third quarter of 2026, the company achieved operating income of 1,249 billion yuan, a year-on-year decrease of 8.22%; net profit attributable to shareholders of listed companies was 374.8873 million yuan, a year-on-year decrease of 6.55%. The company's fundamentals have not changed significantly. Investors are kindly requested to pay attention to investment risks.

According to the Australian Ocean Health announcement, the cumulative deviation value of the company's stock closing price fell by more than 20% for three consecutive trading days on November 4, November 5, and November 6, 2026, which is an abnormal fluctuation in stock trading. After self-inspection and a letter to the controlling shareholder, as of the date of disclosure of the announcement, there was no material information that should have been disclosed but not disclosed, and the controlling shareholder did not trade the company's shares during the period of abnormal fluctuations. As of the third quarter of 2026, the company achieved operating income of 1,249 billion yuan, a year-on-year decrease of 8.22%; net profit attributable to shareholders of listed companies was 374.8873 million yuan, a year-on-year decrease of 6.55%. The company's fundamentals have not changed significantly. Investors are kindly requested to pay attention to investment risks.